Denise Hilfiker-Kleiner received her PhD in 1994 at the University of Zurich and Emory University, Atlanta and her Habilitation 2006 at Hannover Medical School (MHH). She is dean of research of the MHH and leads the Department of Molecular Cardiology. She has a longstanding experience in analyzing signaling pathways in cardiac cells relevant for cardiac physiological and pathophysiological processes. In this regard she explores endogenous regeneration abilities of the heart after pregnancy induced stress, cancer disease and/or treatment with cardio toxic agents. She is a member of a commission which counsels the German Council of Science and Humanities of the German Federal Government and the State. She is a member of the ESC Program Committee, a founding member of the study group on PPCM and of the translational research group of the Heart Failure Association (HFA) of the ESC. She is a core PI of the REBIRTH Excellence Cluster at the MHH and the lead scientist and organizer of the multicenter clinical trial on the efficacy of Bromocriptine in PPCM funded by the German Federal Ministry of Education and Research (BMBF).